Celgene seeks European cancer acquisition (Reuters)


Reuters - Celgene Corp., the U.S. group best known
for reviving thalidomide as a treatment for cancer, is keen to
buy a European company to increase its global reach, Chief
Executive John Jackson said on Thursday.

Read more...